Ontology highlight
ABSTRACT:
SUBMITTER: Hossain DMS
PROVIDER: S-EPMC5785250 | biostudies-literature | 2018 Feb
REPOSITORIES: biostudies-literature
Hossain Dewan Md Sakib DMS Javaid Sarah S Cai Mingmei M Zhang Chunsheng C Sawant Anandi A Hinton Marlene M Sathe Manjiri M Grein Jeff J Blumenschein Wendy W Pinheiro Elaine M EM Chackerian Alissa A
The Journal of clinical investigation 20180116 2
Blockade of the checkpoint inhibitor programmed death 1 (PD1) has demonstrated remarkable success in the clinic for the treatment of cancer; however, a majority of tumors are resistant to anti-PD1 monotherapy. Numerous ongoing clinical combination therapy studies will likely reveal additional therapeutics that complement anti-PD1 blockade. Recent studies found that immunogenic cell death (ICD) improves T cell responses against different tumors, thus indicating that ICD may further augment antitu ...[more]